Ellipsis Health

We envision a future where healthcare is not just reactive but empathetically proactive, using the subtle power of voice to unveil and address complex mental health challenges with precision and compassion.

At Ellipsis Health, we transform care management by harnessing our patented vocal biomarker technology combined with advanced natural language processing to decode the emotional and clinical nuances in patients' voices, empowering clinicians with actionable insights and restoring human dignity to every interaction.

Our mission is to expand the capacity of healthcare providers, streamline workflows, and elevate patient outcomes by forging a new path where technology and empathy coexist to meet the holistic needs of each individual, driving a modern era of healthcare innovation and inclusivity.

We've been tracking Ellipsis Health since 2017, and honestly, we're impressed by how they've turned voice analysis into something that could genuinely transform mental healthcare. Their AI care manager, Sage, doesn't just chat with patients — it listens for subtle vocal cues that can signal depression, anxiety, or stress before they become crisis situations.

What caught our attention isn't just the tech (though analyzing voice patterns for mental health biomarkers is pretty clever). It's how they're solving a real problem: overworked clinicians who barely have time to truly connect with patients who need complex care.

The Empathy Engine That Actually Works

Here's where Ellipsis gets interesting. Their "Empathy Engine" sounds like marketing fluff, but it's actually patent-protected technology that can detect mental health conditions through voice analysis. We've seen plenty of AI health tools that feel cold and robotic — Sage appears designed to do the opposite.

The fact that it integrates directly with existing health records and works during actual telemedicine calls means it's not another standalone tool that nobody uses. It's woven into workflows that already exist.

Follow the Money Trail

The recent $45 million Series A round tells us something important. When Salesforce, Khosla Ventures, and CVS Health Ventures all write checks, they're betting on more than just good intentions. CVS especially doesn't throw money at healthcare tech unless they see a clear path to scaling.

Plus, getting selected as a CMS partner for national healthcare AI transformation? That's not something that happens to companies with shaky foundations.

Who This Really Serves

We think Ellipsis Health works best for large healthcare organizations dealing with high-cost, complex patients — exactly the kind of people who often fall through cracks in our current system. Their partnerships with companies like Ceras Health show they're not just selling to anyone with a budget.

The real test will be whether frontline healthcare workers actually find Sage helpful rather than intrusive. Early signs suggest they're onto something, but we'll be watching how this scales beyond pilot programs.